Silvia Langheim

594 total citations
6 papers, 433 citations indexed

About

Silvia Langheim is a scholar working on Surgery, Epidemiology and Molecular Biology. According to data from OpenAlex, Silvia Langheim has authored 6 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 2 papers in Epidemiology and 1 paper in Molecular Biology. Recurrent topics in Silvia Langheim's work include Lipoproteins and Cardiovascular Health (3 papers), Cholesterol and Lipid Metabolism (2 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper). Silvia Langheim is often cited by papers focused on Lipoproteins and Cardiovascular Health (3 papers), Cholesterol and Lipid Metabolism (2 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper). Silvia Langheim collaborates with scholars based in Italy, United States and Sweden. Silvia Langheim's co-authors include Alfredo Cantàfora, Livia Pisciotta, S. Calandra, Stefano Bertolini, Giovanni Mario Pes, S. Martini, C. Stefanutti, Maurizio Averna, Liqing Yu and Jonathan C. Cohen and has published in prestigious journals such as Journal of Clinical Oncology, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Lipid Research.

In The Last Decade

Silvia Langheim

6 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Langheim Italy 6 282 106 99 86 84 6 433
Hans-Ulrich Kloer Germany 10 286 1.0× 228 2.2× 50 0.5× 116 1.3× 64 0.8× 11 488
Elise F. Villard France 13 296 1.0× 72 0.7× 40 0.4× 117 1.4× 93 1.1× 16 437
Martina F Mohrschladt Netherlands 7 176 0.6× 135 1.3× 44 0.4× 95 1.1× 70 0.8× 8 394
C. Stefanutti Italy 10 339 1.2× 118 1.1× 33 0.3× 153 1.8× 77 0.9× 20 498
Stephanie DerOhannessian United States 11 144 0.5× 136 1.3× 24 0.2× 130 1.5× 122 1.5× 15 438
Kalpna Desai United Kingdom 8 109 0.4× 62 0.6× 32 0.3× 82 1.0× 34 0.4× 15 345
Antoine Rimbert France 12 212 0.8× 112 1.1× 22 0.2× 74 0.9× 114 1.4× 43 457
Takashi Fujisawa Japan 12 261 0.9× 43 0.4× 36 0.4× 29 0.3× 31 0.4× 38 445
Chunhua Lin China 11 119 0.4× 44 0.4× 31 0.3× 87 1.0× 176 2.1× 33 491
Jolanta Krauze Poland 11 89 0.3× 106 1.0× 31 0.3× 42 0.5× 73 0.9× 43 323

Countries citing papers authored by Silvia Langheim

Since Specialization
Citations

This map shows the geographic impact of Silvia Langheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Langheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Langheim more than expected).

Fields of papers citing papers by Silvia Langheim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Langheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Langheim. The network helps show where Silvia Langheim may publish in the future.

Co-authorship network of co-authors of Silvia Langheim

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Langheim. A scholar is included among the top collaborators of Silvia Langheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Langheim. Silvia Langheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Dagna, Lorenzo, Angelo Corti, Silvia Langheim, et al.. (2012). Tumor Necrosis Factor α As a Master Regulator of Inflammation in Erdheim-Chester Disease: Rationale for the Treatment of Patients With Infliximab. Journal of Clinical Oncology. 30(28). e286–e290. 56 indexed citations
2.
Langheim, Silvia, Lorella Dreas, Lorenzo Veschini, et al.. (2010). Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. American Journal of Physiology-Heart and Circulatory Physiology. 298(3). H746–H753. 94 indexed citations
3.
Langheim, Silvia, Liqing Yu, Klaus von Bergmann, et al.. (2005). ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile. Journal of Lipid Research. 46(8). 1732–1738. 80 indexed citations
4.
Bertolini, Stefano, Livia Pisciotta, Lilla Di Scala, et al.. (2004). Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia. Atherosclerosis. 174(1). 57–65. 68 indexed citations
5.
Pisciotta, Livia, Alfredo Cantàfora, Francesco De Stefano, et al.. (2002). A “de novo” mutation of the LDL-receptor gene as the cause of familial hypercholesterolemia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1587(1). 7–11. 12 indexed citations
6.
Bertolini, Stefano, Alfredo Cantàfora, Maurizio Averna, et al.. (2000). Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype. Arteriosclerosis Thrombosis and Vascular Biology. 20(9). E41–52. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026